Press Releases Items Per Page 102550 News Category FinancialGeneral Year None202020192018201720162015201420132012201120102009200820072006 Data Presented from Phase 1b Study of NKTR-358, a Novel T Regulatory Cell Stimulator, at Annual European Congress of Rheumatology (EULAR 2020) Jun 04, 2020 Nektar Therapeutics to Host Webcast Conference Call for Analysts & Investors During 2020 Virtual European Congress of Rheumatology (EULAR 2020) May 29, 2020 Nektar Therapeutics Announces Publication of Results from Phase 1 Dose-Escalation Study for Bempegaldesleukin Plus Nivolumab in 'Cancer Discovery' Journal May 22, 2020 Nektar Therapeutics Reports First Quarter 2020 Financial Results May 07, 2020 Nektar to Announce Financial Results for the First Quarter 2020 on Thursday, May 7, 2020, After Close of U.S.-Based Financial Markets Apr 28, 2020 Nektar Therapeutics to Webcast Presentation at the Cowen and Company 40th Annual Health Care Conference Feb 28, 2020 Nektar Therapeutics Reports Fourth Quarter and Year-End 2019 Financial Results Feb 27, 2020 Nektar to Announce Financial Results for the Fourth Quarter and Year-Ended 2019 on Thursday, February 27, 2020, After Close of U.S.-Based Financial Markets Feb 18, 2020 Nektar Therapeutics Announces Publication of Two Manuscripts on Lead Immuno-oncology Candidate, Bempegaldesleukin (Bempeg) in Nature Communications Feb 03, 2020 Nektar Issues Statement Regarding FDA Advisory Committee Vote for Oxycodegol Jan 14, 2020 Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page next › Last page last »